secwatch.observer — SEC 8-K summary
======================================

Issuer:     Drugs Made In America Acquisition Corp. (DMAA)
CIK:        0002028614
Form:       8-K
Filed at:   2025-01-30T23:59:59+00:00
Accession:  0001213900-25-008377
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Drugs Made In America Acquisition Corp. closes $200M IPO, deposits $201M in trust
--------------------------------------------------------------------------------

- Closed IPO of 20,000,000 units at $10.00 per unit for gross proceeds of $200 million.
- Simultaneous private placement of 400,000 units to sponsor for $4 million, bringing total trust to $201 million.
- Units trade on Nasdaq under DMAAU; ordinary shares (DMAA) and rights (DMAAR) to trade separately later.
- Clear Street acted as sole book-running manager; offering made under effective S-1 registration statement.
- Underwriters have 45-day option for up to 3M additional units to cover over-allotments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea0229135-8k_drugs.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-008377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer